IPI Speaks with Alberto Negra, Technical Manager at Rotor Print about creating a pharmaceutical blister that can be recycled, but without losing the properties of …

IPI Speaks with Dr Patrick Larcier, Senior Director, Strategy Product Development Solutions, EU & US, of PharmaLex, on Next-generation Small Molecules Q: Can we start …

IPI Speaks with Dr. Victor Diaz, Operations Director at Solitek on a New Concept in Solid StateDevelopment Services for the Pharmaceutical, Agrochemical and Fine Chemical …

IPI Speaks with Mr Anil Busimi, VP, Strategy & Marketing of Terumo Medical Care Solutions (TMCS)on the Recent Changes in the CDMO Industry and what …

Christian Schmitz-Moormann, a senior consultant and pharmacovigilance (PV) expert, and partner of Generis, considers the role of this essential master resource in maximising opportunities to …

The global pharmaceutical sector is booming thanks to continued growth in R&D spend in new technologies and therapeutic areas, putting the industry back on a …

Antibody drug conjugates (ADCs) are a big deal in oncology. And rightly so: they combine highly specific targeting with a potent cytotoxic payload to deliver …

The early detection of disease poses a substantial challenge in the field of human health, necessitating the development of more accurate biomarkers, enhanced patient stratification …

Sustainable system for the treatment of vaginal diseases, part I – pre-clinical laboratory study A holistic approach, to address the state of the vaginal biofilm …

The prevalence of decentralised clinical trials, rising demand for preventive healthcare solutions, a market driven by the need for more and better-quality data and the …